International (ICH regions and adopting regulators)

ICH Q7

75 controls. 0 other frameworks in our corpus share controls with it. Here is all of it, and how much of it you are already doing.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

75 controls 0 frameworks share controls with it International (ICH regions and adopting regulators) verified against its source document

Every control below is one this framework asks for. The right hand column counts how many other frameworks in our corpus carry the same control, which is the difference between doing this work once and doing it again for the next standard.

There is no implementation kit for this framework yet. The control list and the overlap above are free and complete.

What you already have

Frameworks whose controls overlap this one, most first. If you run any of them, the count is roughly what you have already evidenced.

No measured overlap with another framework in the corpus.

Every control

CodeControlAlso in
1.1-1.3Objective, regulatory applicability and scope of the guide0
1.3-startDesignate and justify the point at which API production begins (the API starting material) and apply GMP from that step onward, with stringency rising towards final steps0
10.1-10.2Store materials under recorded appropriate conditions with segregated quarantine, rejected, returned and recalled stock, distribute only quality-released product, control transport0
11.1Give the quality unit adequate laboratories, documented sampling and test procedures, scientifically sound quality-approved specifications consistent with the filing, OOS investiga0
11.2Test each batch of intermediate and API for conformance, establish and periodically compare an impurity profile for each API, and run microbiological tests where microbial quality 0
11.4Issue authentic, signed certificates of analysis on request that show the product, batch, release date, dating, each test with limits and numerical results, and the original manufa0
11.5Run a documented, ongoing stability programme with validated stability-indicating methods to confirm storage conditions and retest or expiry dates0
11.6Base API expiry or retest dates on stability data (pilot batches allowed for preliminary dates when representative) and support dating of intermediates shipped outside the company0
11.7Retain identified reserve samples of each API batch for the required period, in equivalent or more protective packaging and in enough quantity for two full analyses0
12.1-12.2Document a validation policy, identify critical parameters and attributes, and validate critical operations under quality-approved protocols and reports that address deviations0
12.3Complete design, installation, operational and performance qualification of critical equipment and ancillary systems before process validation0
12.4-12.5Validate API processes, normally prospectively before commercial distribution of the medicine, using concurrent or retrospective approaches only where their conditions are met, wit0
12.6Periodically evaluate validated systems and processes to confirm they remain in a validated state0
12.7Validate cleaning procedures where carry-over poses the greatest risk, with representative worst-case selection, a full protocol, suitable sampling and validated sensitive methods,0
12.8Validate analytical methods (or verify compendial ones under actual use) per the ICH validation guidelines, qualify analytical equipment first and record any method modification wi0
13Operate a formal change control system: quality unit approval, impact evaluation and classification, document updates, evaluation of first batches, stability impact and notificatio0
14.1-14.2Quarantine and record the disposition of out-of-specification material, and reprocess only by repeating established steps, building routine reprocessing into the process and evalua0
14.3Investigate non-conformance before reworking, then show reworked batches are of equivalent quality by evaluation, testing, stability where warranted and impurity profile comparison0
14.4Recover reactants, intermediates, APIs and solvents only under approved, controlled and monitored procedures with documented use and proven suitability0
14.5Quarantine returned intermediates and APIs, reprocess, rework or destroy them where storage or container condition casts doubt, and record each return0
15Record and investigate all quality complaints under a written procedure, trend them, keep a recall procedure, and inform authorities in serious or life-threatening situations0
16Evaluate contract manufacturers and laboratories for GMP, set written GMP responsibilities with audit rights, control subcontracting and changes, and keep records at the contract s0
17.1-17.3Agents, brokers, traders, distributors, repackers and relabellers comply with GMP, operate a quality system and keep complete traceability documents for every API and intermediate 0
17.4-17.5Repack, relabel and hold APIs under GMP controls and suitable environmental conditions, and run stability studies when repacking into a different container type0
17.6Pass all quality and regulatory information between the manufacturer and the customer, name the original manufacturer and batch, disclose the manufacturer to authorities on request0
17.7-17.8Distributors and repackers record complaints and recalls, review them with the original manufacturer where warranted, keep the manufacturer's responses, and handle and document ret0
18.1Control every stage of cell culture and fermentation APIs: appropriate prior steps, environmental controls matched to open or closed processing, process controls for cell banks, cu0
18.1-introSection 18 general: specific guidance for APIs made by cell culture or fermentation0
18.2Restrict access to cell banks, store them to keep viability and prevent contamination, record vial use and storage and monitor suitability0
18.3Use closed systems or controlled environments for aseptic additions and open manipulations, monitor critical culture parameters, clean and sterilise equipment and media, and detect0
18.4Harvest and purify in equipment and areas that minimise contamination, with procedures that consistently remove the organism, debris and media, clean equipment after use and add co0
18.5Run viral removal and inactivation steps within validated parameters and prevent virus carry-over by segregation, separate air handling and cleaning0
19.1-19.3Manufacture clinical trial APIs in suitable facilities with stage-appropriate GMP, an independent quality unit approving each batch, material testing, problem evaluation, investiga0
19.1-introSection 19 general: APIs for use in clinical trials0
19.4-19.5Evaluate raw materials for clinical APIs by testing or supplier analysis with identity testing, and document production in notebooks or batch records0
19.6-19.7Validate processes per section 12 once batches are for commercial use, even at pilot scale, and record every change to production, specifications or test procedures during developm0
19.8-19.9Use scientifically sound methods for clinical batches, retain reserve samples and records for an appropriate period after the application ends, apply dating rules to existing APIs 0
2.1Run an effective, documented quality management system with management involvement and an independent quality unit covering both QA and QC0
2.2Keep the quality unit involved in every quality matter and assign it, in writing and without delegation, the core release, approval and oversight responsibilities0
2.3Define production's responsibilities in writing, from approved instructions and completed batch records to deviation reporting, clean facilities, calibration, maintenance and quali0
2.4Perform scheduled internal audits (self-inspections) of GMP compliance, report findings to management and close corrective actions on time0
2.5Conduct and document a product quality review of each API, normally every year, and act on what it shows0
20Section 20: glossary of terms0
3.1Staff manufacture with enough qualified people, written responsibilities and regular, recorded, periodically assessed GMP training0
3.2Enforce personnel hygiene: suitable clean clothing and protective wear, no direct contact with product, food and smoking kept to set areas, and exclusion of ill workers0
3.3Use only suitably qualified consultants and keep records of their name, address, qualifications and service0
4.1Design buildings and material and people flows to ease cleaning and maintenance, prevent mix-ups and contamination, and provide defined areas for each activity0
4.2Qualify and monitor utilities that can affect product (steam, gases, compressed air, HVAC), control air handling and recirculation, identify pipework and protect drains0
4.3Show process water is fit for use (at least drinking-water quality unless justified), set tighter specifications where needed and validate any in-house treatment0
4.4Use dedicated production areas for highly sensitising materials such as penicillins and cephalosporins, consider them for highly potent or infectious materials, and keep toxic non-0
4.5-4.6Provide adequate lighting in all areas and dispose of sewage, refuse and process waste safely, promptly and hygienically in identified containers0
4.7Keep buildings maintained, repaired and clean under written sanitation procedures, including controlled use of pest control agents and cleaning chemicals0
5.1Design, build, identify and use process equipment so it suits its purpose, does not alter product, stays within its qualified range and has current drawings0
5.2Maintain equipment preventively and clean it under detailed written procedures with justified residue limits, status labelling and controls against carry-over0
5.3Calibrate critical control, weighing, measuring, monitoring and test equipment to a written schedule against traceable standards, and investigate out-of-calibration findings0
5.4Validate GMP computerised systems and control access, data changes, data entry, incidents, changes, backup and data protection0
6.1Control GMP documents through their life cycle, specify retention periods and keep production, control and distribution records for the minimum times0
6.2Keep equipment use, cleaning, sanitisation, sterilisation and maintenance logs that identify the date, product, batch and person0
6.3Record receipt, testing, use and disposition of raw materials, intermediates, labels and packaging materials, and keep master labels for comparison0
6.4Prepare master production instructions for each intermediate and API, signed by one person and independently checked and signed by the quality unit, with the full content set0
6.5Issue a checked, uniquely numbered batch production record for each batch, document each significant step, and investigate critical deviations and failures across related batches0
6.6Keep complete laboratory control records: samples, methods, weights, raw data, calculations, results against criteria, analyst signature and second-person review0
6.7Review and approve batch production and laboratory records, including all deviation, investigation and OOS reports, before release; the quality unit reviews critical steps0
7.1Govern materials under written procedures and buy critical materials against agreed specifications from quality-approved suppliers whose actual manufacturer is known0
7.2Inspect each incoming container, quarantine materials until released, prevent wrong discharge into existing stock, assure tanker cleanliness and give every lot a distinctive code a0
7.3Test at least identity on each incoming batch, rely on supplier certificates only after supplier qualification with periodic full testing, justify exemptions and sample representat0
7.4-7.5Store materials to prevent degradation and contamination, off the floor, oldest first, with rejected stock quarantined, and re-evaluate materials after prolonged storage or exposur0
8.1Weigh and subdivide materials accurately into identified containers, witness critical operations, compare actual and expected yields, investigate deviations and show equipment proc0
8.2Meet time limits set in the master instructions, document and evaluate deviations, and hold intermediates under suitable conditions0
8.3Define and approve in-process controls and sampling procedures, record all results in the batch record and protect in-process sample integrity0
8.4Blend only batches that individually meet specification, never to rescue out-of-specification batches; control, document, trace, validate where attributes are critical and date by 0
8.5Control carry-over of residues between successive batches and prevent contamination of intermediates and APIs, especially after purification0
9.1-9.2Control receipt, testing and release of packaging and labelling materials, reject non-conforming ones, and use clean, non-reactive containers that protect the product0
9.3Restrict access to labels, reconcile labels issued, used and returned, destroy excess and obsolete labels, control printing devices and keep a representative label in the batch rec0
9.4Run packaging and labelling to prevent mix-ups, label containers with the required identity, batch, storage, manufacturer and dating information, line-clear before use, check label0

Tell me when ICH Q7 files something new

One email when a public company newly discloses something this framework governs, naming the company and what our corpus says it puts in scope. Nothing else, and one click to stop.

What this page is

A control-level reference for ICH Q7, drawn from our framework corpus. Control codes and titles are references to the standard, not reproductions of it. The overlap counts and the auditor artefacts are our own work and are the part you will not find elsewhere.

Measure this against what you already run · All frameworks · Today's edition